There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate the efficacy of topically applied autologous plasma rich in growth factors
(PRGF) as a treatment for persistent epithelial defects (PEDs) of the cornea.